Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse 21:00:02 17/06/2024 BST 5-day change 1st Jan Change
76.19 USD -0.74% Intraday chart for Boston Scientific Corporation -1.59% +31.79%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Baird Adjusts Price Target on Boston Scientific to $90 From $84 MT
GE Healthcare Technologies Inc. Announces Management Changes CI
Boston Scientific Insider Sold Shares Worth $526,029, According to a Recent SEC Filing MT
Boston Scientific Insider Sold Shares Worth $4,791,447, According to a Recent SEC Filing MT
Transcript : Boston Scientific Corporation Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-29-2024 08:00 AM
Argus Adjusts Price Target on Boston Scientific to $95 From $80 MT
Boston Scientific Insider Sold Shares Worth $2,504,239, According to a Recent SEC Filing MT
Medtronic beats quarterly profit estimates on medical devices strength RE
Citigroup Adjusts Price Target on Boston Scientific to $87 From $85, Keeps Buy Rating MT
CL King Adjusts Price Target on Boston Scientific to $90 From $82 MT
Boston Scientific Corporation Announces Positive Six-Month Results from the Ongoing Pivotal Modular ATP Clinical Trial of the mCRM System CI
Mizuho Adjusts Price Target on Boston Scientific to $90 From $85, Keeps Buy Rating MT
Transcript : Boston Scientific Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM
Boston Scientific Insider Sold Shares Worth $958,717, According to a Recent SEC Filing MT
Boston Scientific Insider Sold Shares Worth $286,874, According to a Recent SEC Filing MT
Boston Scientific Corporation Appoints Cheryl Pegus to its Board of Directors CI
Boston Scientific Insider Sold Shares Worth $1,257,488, According to a Recent SEC Filing MT
Boston Scientific Insider Sold Shares Worth $499,075, According to a Recent SEC Filing MT
Boston Scientific Insider Sold Shares Worth $719,562, According to a Recent SEC Filing MT
Daiwa Adjusts Price Target on Boston Scientific to $81 From $73 MT
Redburn Atlantic Adjusts Price Target on Boston Scientific to $79 From $75 MT
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength RE
UBS Raises Boston Scientific's Price Target to $90 From $74, Maintains Buy Rating MT
Oppenheimer Adjusts Boston Scientific's Price Target to $77 From $68 MT
Bernstein Adjusts Boston Scientific Price Target to $86 From $75 MT
Chart Boston Scientific Corporation
More charts
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
76.19 USD
Average target price
82.26 USD
Spread / Average Target
+7.96%
Consensus
  1. Stock Market
  2. Equities
  3. BSX Stock
  4. News Boston Scientific Corporation
  5. Boston Scientific Insider Sold Shares Worth $1,257,488, According to a Recent SEC Filing
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW